Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
?

?

0.690%
0.12
0.690%
-

-

 
09:32 / Stuttgart Stock Exchange WKN: A2DG49 / Name: KalVista / Stock / Pharmaceuticals / Small Cap /
Latest predictions
17.03.26
22.04%
buy
Best running prediction
-
17.03.26
22.04%
buy
Your prediction

Carbylan Therapeutics Inc Stock

Carbylan Therapeutics Inc gained 0.690% compared to yesterday.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Carbylan Therapeutics Inc stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Carbylan Therapeutics Inc in the next few years

Pros
?
B****
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
M***** P*******
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Carbylan Therapeutics Inc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Carbylan Therapeutics Inc 0.690% -0.349% 23.309% 82.340% 34.961% 139.720% -21.376%
Pharma Mar S.A. 2.300% 0.056% 10.386% 24.649% 17.940% 106.684% -8.881%
Clinuvel Pharmaceuticals 4.900% -5.442% -6.802% -5.034% -22.038% -53.519% -69.653%
Cicassia Pharmaceuticals -3.200% -6.923% -12.950% -15.972% -17.123% 23.975% 91.456%